The toxins could potentially be used as ‘markers’ for doctors to identify Parkinson’s patients at a higher risk of developing ...

Changes in the bacteria found in the mouth and gut of Parkinson’s disease patients could act as an early warning sign that their symptoms are worsening, new research suggests. Scientists, using ...

Ambroxol showed target engagement in Parkinson's dementia but no significant cognitive improvement over placebo. The drug, a common cough medicine in Europe, was safe and well-tolerated. Ambroxol ...

Researchers in Japan discovered that Parkinson’s patients diagnosed in their 80s are far more likely to show signs of amyloid buildup, a hallmark of Alzheimer’s, even without dementia symptoms. The ...

Dear Dr. Roach: I'm a 65-year-old and otherwise healthy male. After spending the past five years believing that my trembling hands were the result of essential tremor, a second DaT (dopamine ...

If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...

A safe and affordable treatment to slow the advancement of Parkinson's dementia has emerged – in the form of a commonly available cough syrup that's already being studied for its positive effect on ...

Changes in the bacteria found in the mouth and gut of Parkinson’s disease patients could act as an early warning sign that their symptoms are worsening, new research suggests. Scientists, using ...

Ambroxol, a common cough medicine used in Europe, demonstrated target engagement in people with Parkinson's disease dementia but did not show an effect on cognition compared with placebo, a year-long ...